Zai Lab Ltd
ZLABHealthcare|Biotechnology|China
$20.49
+0.52 (+2.60%)
Tangible Book
$5.25
About
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Stock Price
-39.9%(1Y)
Pipeline Summary
44 total trials18
Phase 1
19
Phase 2
11
Phase 3
0
Phase 4
Completed: 18Unknown: 8Recruiting: 10Terminated: 6NOT_YET_RECRUITING: 1Active: 1
Active Trials (11)
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
NCT06380907Plaque Psoriasis
Phase 2Recruiting
Enrollment: 250 participants
A Study of ZL-1310 in Participants With Selected Solid Tumors
NCT06885281Solid Tumors
Phase 1Phase 2Recruiting
Enrollment: 166 participants
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
NCT07211776Thyroid Eye Disease (TED)
Phase 3Recruiting
Enrollment: 99 participants
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
NCT07235384Atopic Dermatitis (AD)
Phase 1Recruiting
Enrollment: 84 participants
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146Small-cell Lung Cancer
Phase 3Recruiting
Enrollment: 480 participants
BioScore
4.1/10
Cautious
Ownership
Recent Insider Trades
GAYNOR RICHARDBUY
2026-07-011,736 shares @ $19.05
Du YingSELL
2026-06-307,026 shares @ $18.53
Edmondson Frazor Titus IIISELL
2026-06-264,103 shares @ $17.46
Du YingSELL
2026-06-2624,543 shares @ $17.46
Chen YajingSELL
2026-06-262,264 shares @ $17.46
Recent News
2026-06-25 04:06:22
2026-06-16 12:00:10
2026-06-16 11:35:21
Data last updated: Jul 12, 2026, 07:36 PM